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Abstract
Background: Senecio biafrae (Asteraceae) is a medicinal plant widely used by traditional healers in the western
region of Cameroon for the treatment of female infertility. This experiment was designed to evaluate the effect of
the aqueous extract from leaves and stems of S. biafrae (AESb) on the onset of puberty and some biochemical and
physiological parameters of reproduction in immature Wistar female rats.
Methods: Different doses of AESb were daily and orally administered to immature female rats (13 animals/group)
for 30 days. At the end of the treatment period, six animal of each experimental group were sacrificed and their
body, ovarian, uterus weight; uterine, ovarian protein or cholesterol level as well as data on puberty onset
recorded. The remaining animals of each group were used for the fertility test and some gestational parameters
recorded.
Results: A linear increase in the growth rate of all animals was observed. The body weight gain in animals treated
at the dose of 8 mg/kg of AESb significantly increased (p < 0.05) after 25 days of treatment while those receiving
the doses of 32 and 64 mg/kg presented a significantly low body weight gain starting from the 19
th day till the
end of the treatment period. The ages (days) of animals at vaginal opening (VO) was significantly reduced (p <
0.05) in those treated with the doses of 32 (41.25 ± 0.51) and 64 mg/kg (41.42 ± 0.54) as compared to control
animals (43.33 ± 0.73). AESb significantly increased (p < 0.05) the ovarian weight and the number of corpora lutea
in animals treated with 8 mg/kg as well as the uterine weight and protein levels irrespective of the dose. No
significant effect of the extract on various fertility and gestational parameters was registered.
Conclusion: The overall results of the present study provide evidence on the puberty onset induction and ovarian
folliculogenesis effect of AESb in immature female rat.
Background
Medicinal Plants have been used for many years in daily
life to treat diseases all over the world [1,2]. According
to the World Health Organization (WHO), more than
three-quarters of the world’s population rely upon com-
plementary and alternative medicine for health care [3].
Many medicinal plants are used to treat various repro-
ductive function ailments such as female infertility
which is a public health concern in Sub-Saharan African
countries [4]. Senecio biafrae (Oliv. & Hiern) J. Moore
(Asteraceae) (syns. Crassocephalum biafrae and Solane-
cio biafrae) is one of these plants [5]. It is a perennial
climbing herb which naturally occurs in African forest
zones, from Guinea to Uganda. Its leaves contain var-
ious secondary metabolites such as dihydroisocoumar-
ins, terpenoids, sesquiterpenes or amino acids [6-8].
Senecio biafrae is equally known for its therapeutic vir-
tues, notably in Nigeria where it is used in the treatment
of diabetes or pulmonary defects [9-11]. In Benin, Côte
d’Ivoire, Congo, or Cameroon it is used in traditional
medicine to treat many diseases such as bleeding from
cuts, sore eyes, cough, heart troubles, rheumatic pain, or
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tern Regions of Cameroon, ethnobotanical studies
revealed its utilization in the treatment of cases of
women infertility [5,12].
Many conditions can be associated to infertility,
among which non avoidable factors (anatomic, genetic,
hormonal and immunological problems) and avoidable
factors such as Sexually Transmitted Infections (STI),
infections after parturition or surgery, tuberculosis of
the pelvis, and obesity [13,14]. A range of medical and
alternative treatments exist for infertility. They include
the use of fertility drugs to stimulate “superovulation”,
intrauterine insemination, Assisted Reproductive Tech-
nologies (ARTs) and medicinal plants preparation to
which most of the infertile couple in developing coun-
tries generally rely for their treatment [15,16].
Many studies have indicated the implication of sec-
ondary metabolites from medicinal plants on the regu-
lation of reproductive functions [17-21]. These
metabolites act on main organs of the reproductive
system to inhibit or induce ovarian folliculogenesis.
Their biological activities are often evaluated on repro-
ductive organs of immature female rats which have
long been used as a model system for studying, in vivo,
the inducing effect of pharmacological compounds
[22,23] and medicinal plants [18,24,25] on ovarian fol-
liculogenesis. In those various studies, the gonado-
trophic-like effects of the preparation was
characterized by the following biological parameters:
increase in the weight of the ovary and uterus; opening
and cornification of the vagina; formation of corpora
lutea or changes in the histology of the ovary, uterus
and vagina; induction of ovulation; increase in ovarian
estradiol, progesterone, protein levels; decrease in ovar-
ian cholesterol level.
The leaves and stems of Senecio biafrae are used
either macerated in water or in palm wine by traditional
healers of our locality to treat cases of women infertility
[5]. Our previous studies on the effect of its ethanolic
extract on some physiological parameters of reproduc-
tion showed an increase in ovarian or uteri weights and
proteins as well as an acceleration of the onset of pub-
erty in immature female rats [26]. The present study
therefore aimed at evaluating the effect of the aqueous
extract of S. biafrae (AESb) on similar parameters of
sexual maturation (puberty onset, fertility induction) in
immature female rat. The precocity of the puberty onset
in treated animals was evaluated through the determina-
tion of their age at vaginal opening and the inducing
effect of the extract on animal fertility evaluated through
the determination of ovarian and uterine weights, pro-
tein or cholesterol levels; number of corpora lutea,
implantation sites and other gestational parameters.
Methods
Preparation of the extract
The fresh leaves and stems of S. biafrae were collected
in May 2010 in Baham subdivision (Western Region of
Cameroon) and identified at the National Herbarium of
Cameroon under voucher specimen code 32999/SRF/
Cam. These plant parts were washed and dried at room
temperature. The dried plants were ground in a mortar
and the powder obtained used to prepare the aqueous
extract by maceration in distilled water for 24 h. At the
end of this period, the solution was filtered before being
d r i e di nav e n t i l a t e do v e na t4 5 ° C .T h ed r yp o w d e rw a s
weighed and stored at 4°C in a refrigerator. The yield of
extraction was 16.6%. The extracts were prepared in dis-
tilled water at concentrations of 2.8 mg/ml (extract 1),
11.2 mg/ml (extract 2) and 22.4 mg/ml (extract 3).
Together with distilled water (control group), these pre-
parations (extracts 1, 2 and 3) were orally administered
to animals in a volume of 3 ml/kg body weight, corre-
sponding to doses of 0, 8, 32, and 64 mg/kg respectively.
The dose of 8 mg/kg was reconstituted on the basis of
information from traditional medicine practitioners in
an ethnopharmacological survey performed in Baham
subdivision (Western Region of Cameroon), and the two
other doses (32 and 64 mg/kg) were its multiples
Animals
The animals used in this study were immature female
albino Wistar rats, 21-22 days old, weighing 30-45 g.
They were bred in the animal house of the Biochemistry
Department (University of Dschang, Cameroon), housed
under natural conditions of light (12 h cycle) and tem-
perature (22 ± 2°C) and fed with a standard laboratory
diet and tap water ad libitum.
Ethical consideration
Experimental protocols used in this study strictly con-
formed with the internationally accepted standard ethi-
cal guidelines for laboratory animal use and care as
described in the European Community guidelines; EEC
Directive 86/609/EEC, of the 24th November 1986 [27].
Puberty onset and fertility assays
A total of fifty-two immature female rats were rando-
m i z e d ,b a s e do nt h e i rb o d yw e i g h t ,i n t o4g r o u p so f
thirteen animals each. They received by gavage, either
distilled water or different doses of AESb for 30 conse-
cutive days. Their body weight and food intake were
recorded, throughout the experimental period, at 2 day
intervals. After two weeks of treatment, each rat was
checked every day for vaginal opening and the vaginal
smear collected and stained from the day of opening up
to the end of the experiment. The vaginal smears were
stained by May-Grünwald solution (1%w/v) followed by
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cation (40 ×) under a light microscope. This staining
helped in characterizing each phase of the rat’se s t r o u s
cycle, its length and that of the complete cycle. At the
end of the experimental period, 6 animals in each group
were randomly sacrificed by anesthesia using chloro-
form. Their ovaries and uteri were removed, blotted,
weighed and stored at - 20°C until use.
The remaining rats (7 per group) were crossed the fol-
lowing day, during two weeks, with males of proven fer-
tility. Vaginal smears were collected on a daily basis in
order to assess for the presence of sperm. A laparoscopy
was undertaken under diazepam (5 mg/ml, 5 mg/kg)
and Ketamin (50 mg/ml, 80 mg/kg) ten days after the
day of mating to count the number of implantation sites
in uterine cords and the number of corpora lutea in
ovaries. After delivery, the fetuses were weighed and
their number recorded. From these data, the number of
resorption sites (number of implantation site - number
of live fetuses), implantation index ([total number of
implantation sites/number corpora lutea] × 100), resorp-
tion index ([total number of resorption sites/total num-
ber of implantation sites] × 100), preimplantation loss
([number of corpora lutea - number of implantations/
number of corpora lutea] × 100), postimplantation loss
([number of implantations × number of life fetuses/
number of implantations] × 100), antifertility activity
([number of females without life fetuses/total number of
females] × 100), antiimplantation activity ([number of
females without implantation sites/total number of
females] × 100), and gestation rate ([number of females
with life fetuses at birth/total number of gestational
females] × 100) were calculated [28].
Preparation of the uterine and ovarian supernatants and
biochemical analysis
Ovaries and uteri were homogenized in Tris - sucrose
buffer (0.25 M sucrose, 1 mM EDTA and 10 mM Tris-
HCl, pH 7.4) at 1% and 2% respectively. The homoge-
nate was then centrifuged at 6000 × g at 4°C (Beckman
model J2-21) for 15 min, and the supernatants collected
were used for protein [29] and cholesterol [30-32]
assays.
Statistical analysis
The data from biological assays were treated by the one
way Analysis of Variance (ANOVA) test and presented
as Mean ± SEM (standard error on the mean). The
Fisher PLSD test was used for the comparison of means.
The analysis of percentages was done by X
2 (Chi-
square) test. The Kruskall-Wallis test was used for non
parametrical data, and the Mann Whitney test used
when their differences were significant [33].
Results
Effect of AESb on body weight gain and food intake
T h ee f f e c to fA E S bo nt h eb o d yw e i g h to ff e m a l er a t s
during the treatment is presented in Figure 1. There
was a linear increase, at various rates, in their growth.
Compared to control animals, a significant drop in the
body weight of animals treated with the doses of 32 and
64 mg/kg was indeed noticed after 19 days of treatment.
Animals receiving the 8 mg/kg dose instead gained
more weight (p < 0.05) compared to control animals,
starting from the 25th day of treatment till the end of
the experiment. As concerns the monitoring of their
food intake, no significant variation, whatever the dura-
tion of the treatment, was observed between the differ-
ent experimental groups (Figure 2).
Effect of AESb on the age and estrous cycle phases at
vaginal opening
Figure 3 shows the mean age of animals at vaginal open-
ing and the percentage of those presenting vaginal aper-
ture at a given age. Female rats that received AESb at
the two highest doses presented vaginal opening almost
two days earlier (p < 0.05) as compared to the control
animals [43.33 ± 0.73 days (0 mg/kg) vs 41.25 ± 0.51
days (32 mg/kg) or 41.42 ± 0.54 days (64 mg/kg)].
About 8% of 38 days old rats treated at 32 mg/kg
(against 0% for its respective control) presented vaginal
aperture. This percentage was significantly increased in
these animals and in those treated at 64 mg/kg dose
when they were 42 or 43 days old (92% with the two
doses compared to 48% with 0 mg/kg). Moreover, com-
plete vaginal opening was obtained in all animals of
these experimental groups (32 and 64 mg/kg) when they
were 45 or 46 days old, contrary to those of the control
group for which it was obtained at the age of 50. Most
of these animals presented an estrus (23% - 46%) or
metoestrus (8%-46%) vaginal cycle phase on the day of
their vaginal opening (Table 1).
Effect of AESb on the estrous cycle length
No changes in the estrous cycle length of animals of
various experimental groups as well as in the duration
of the estrus, metestrus and diestrus phases of their
cycle were observed (Table 2). However, a slight
decrease in the duration of the proestrus phase of ani-
mals treated at the dose of 8 and 32 mg/kg was
recorded.
Effect of AESb on ovarian weight, protein or cholesterol
level and corpora lutea number
The changes obtained in ovaries after 30 days of oral
administration of various doses of AESb to immature
rats are presented in Figure 4. No significant variations
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(data not shown). When administered at the dose of 8
mg/kg and in comparison to the control group, the
extract significantly increased (P < 0.05) the number of
corpora lutea, and the relative weight of ovaries (Figure
4A and 4B).
Effect of AESb on uterine weight and proteins
Oral administration of AESb to immature female rats
significantly increased the weight of their uteri irrespec-
tive the dose administered (Figure 5A). Uterine proteins
were also increased in these animals notably by two (8
mg/kg) to three fold (32 and 64 mg/kg; P < 0.01) (Figure
5B).
Effect of AESb on some fertility and gestational
parameters
Table 3 shows that oral administration of AESb at doses
of 8, 32 and 64 mg/kg showed no significant effect on
the number of pregnant rats, implantation sites and fetal
weight. However, a slight increase in the number of
resorption sites at the dose of 64 mg/kg was obtained.
This resulted in antiimplantation and antifertility activ-
ities of 14% and 29% respectively.
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Figure 1 Body weight gain of rats after administration of various doses of AESb. Each point represents mean ± SEM of 13 animals per
group. *Values statistically different from that of the control group of each day at P < 0.05 (ANOVA and Fisher PLSD).
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Figure 2 Food intake of animals in function of the duration of treatment with various doses of AESb. Each point represents mean ± SEM
of 13 animals per group.
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Senecio biafrae, which is the plant of interest in this
study, is used by some people in Africa for its nutri-
tional and pharmacological properties [6,7,9-11]. Its
effect on the onset of puberty (age and phase of the
estrous cycle at vaginal opening) and the ovarian follicu-
logenesis of immature female rats were evaluated. The
choice of these parameters was not only guided by the
influence of the gonadotrophic hormones (FSH, LH,
PMSG, GnRH) on the precocious onset of puberty and
the induction of the follicular growth in immature
female rats, but also by the clinical usage of these hor-
mones in the treatment of various forms of infertility
(ovulatory defects or hypogonadal infertility) [34]. Pub-
erty is the culmination of a complete sequence of
maturational events that lead to the activation of the
gonadotrophic axis, linked to the increase in serum
levels of LH and FSH and attainment of sexual maturity.
Estradiol has been reported to peak just before the
vaginal opening in female rats, showing that it is the
effective molecule for puberty induction [35]. In various
mammals, precocious puberty onset can be induced in a
prepubertal animal by repeated injections of GnRH,
FSH, LH or of an analogous compound of a general
excitatory neurotransmitter of the central nervous sys-
tem, like glutamate or aspartate which induce the pulsa-
tile releases of GnRH [36]. The pulsatile secretion of
GnRH hormone at puberty leads to the pulsatile release
of FSH and LH. These pituitary hormones in turn
enhance the proliferation of the follicular cells and the
production of estrogens (principally estradiol) by ovarian
cholesterol catabolism [37]. The overall hormonal signa-
lization culminates in the opening and cornification of
the vagina, and to the increase in ovarian and uterine
weight [38].
Oral administration of AESb for 30 days, at doses of
32 and 64 mg/kg, to immature female rats led to a
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Figure 3 Effect of prepubertal oral administration of AESb on the timing of Puberty onset. Shown on the left are mean day of vaginal
opening in control and prepubertal AESb-treated animals. Shown on the right are percentages of animal showing vaginal opening as a function
of age in the control and AESb-treated animals. *Values significantly different at p < 0.05 from those of the control group (Kruskal-Wallis
followed by Mann-Whitney tests for histograms and Khi Square followed by Fisher Exact tests for lines); each data represents the mean ± SEM of
13 animals.
Table 1 Frequency (%) of estrous cycle phases at vaginal
opening in female rats treated with various doses of
AESb
Cycle phases Total
Doses Proestrus Œstrus Metoestrus Diestrus
0 mg/kg 19.05 42.9 33.3 4.8 100
8 mg/kg 23.1 46.2 7.7 23.1 100
32 mg/kg 23.1 23.1 46.2 7.7 100
64 mg/kg 38.5 38.5 15.4 7.7 100
(Fisher exact and Khi square tests).
Table 2 Effect of AESb on the duration (days) of the
various phases in the estrous cycle
Doses Phases of the estrous
cycle
Proestrus Estrus Metestrus Diestrus Cycle
Length
0 mg/kg 0.80 ± 0.17 1.38 ± 0.19 0.57 ± 0.11 1.22 ± 0.16 4.00 ± 0.16
8 mg/kg 0.56 ± 0.10 1.60 ± 0.19 0.57 ± 0.12 1.27 ± 0.15 4.00 ± 0.11
32 mg/kg 0.65 ± 0.13 1.58 ± 0.24 0.35 ± 0.07 1.42 ± 0.17 4.00 ± 0.19
64 mg/kg 0.75 ± 0.17 1.25 ± 0.19 0.73 ± 0.14 1.28 ± 0.11 4.01 ± 0.15
The length of the phases is expressed as days. Each value represents the mean
± SEM for 13 animals
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Page 5 of 9precocious onset of vaginal opening. This shows that the
plant extract could contain molecules acting, as one of
the above compounds, on the precocious onset of pub-
erty. The same result was obtained, at 8 mg/kg dose,
with the ethanolic extract of the plant [26]. This shows
that the active compound of the plant would be more
extracted by organic solvents.
The opening of the vagina on attainment of the pub-
ertal age of rats resulted from the increase in the
secretion of estrogens by ovarian follicles. The vaginal
cells are also keratinized in this high estrogenic environ-
ment [39]. That is why the vaginal smear of pubertal
rats the day of vaginal opening corresponds to the estrus
phase of the cycle or to the nearest phase following it
(metoestrus), as shown in Table 1. In animals treated
with 8 and 32 mg/kg doses, the proestrus phase (preo-
vulatory phase) was slightly reduced. This could be
linked to the acceleration in the ovarian follicular
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Figure 4 Effect of AESb on the relative weight of the ovaries (A) and the number of corpora lutea (B). *Values significantly different at (p
< 0.05) from those of the control group (ANOVA and Fisher PLSD). Each histogram represents the mean ± SEM of the values for 6 animals.
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Figure 5 Effect of AESb on uterine relative weight (A) and uterine proteins level (B). *Values significantly different at (p < 0.05) from those
of the control group (ANOVA and Fisher PLSD); each histogram represents the mean ± SEM of the values for 6 animals.
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Page 6 of 9growth, given the high estrogenic environment of the
ovarian cells, following the induction of pulsatile secre-
tion of GnRH and gonadotrophins by AESb.
A significant reduction in the body weight gain of ani-
mals, after three weeks of oral administration of AESB,
was also noticed. During the same period of treatment,
no significant changes in various biochemical para-
meters of toxicity (data not shown) nor in the daily food
intake of AESB treated animals was observed. Thus, this
body weight reduction may be related to the cumulated
slight decrease, during the same period of treatment, in
food intake of those treated with the doses of 32 or 64
mg/kg of AESB.
Estrogens and estrogen-like compounds (phytoestro-
gens) are well known regulators of growth and differen-
tiation in a number of tissues. They exert their
biological effect following their fixation to the receptors
in their main target organs (ovary, uterus, hypothalamus,
bone,...) thus leading to a chain of reactions, culminating
in the biosynthesis of biomacromolecules (DNA, RNA,
and proteins) and the increase in the weight of these
organs, principally the ovary and uterus [1,40,41]. This
weight increase is a combination of hypertrophic
response of tissues following cell proliferative activities
and water imbibition in the tissue [42]. The data on
uterine parameters presented in this study has shown an
increase of more than 96% and 87% in uterine proteins
and uterine weight respectively, at all the doses. This
increase in uterine proteins and weight may have
resulted not only from the uterine cell proliferation
induced by the oestrogenic effects of some chemical
components of AESB but also from the increase in their
water imbibition effect, especially at low dosage, in these
cells. This estrogenic potential of AESB is also attested
with the increase, at the dose of 8 mg/kg, in ovarian
weight and corpora lutea number.
As concerns the test on gestational parameters, a
slight reduction in the number of corpora lutea, and
gestational rate with the highest dose (64 mg/kg) could
be linked to the reduction in the ovulation rate of these
animals following the negative feed-back effect, at the
level of the hypothalamus, of high estrogen level
induced by this dose of the extract [37]. This could also
results from the fact that estrogenic compounds cause
contraction in the uterine smooth muscle, which could
lead to the resorption of the fetus after its implantation
[43].
Conclusion
Globally, this study has proven the implication of some
compounds present in AESb on the rapid maturation of
ovarian follicular cells leading to a precocious puberty
onset. The mechanisms of this stimulation are multiple
(induction of GnRH synthesis or secretion, induction of
gonadotrophin synthesis or secretion, effects of estro-
gens-like compounds or specific amino acids present in
the extract). Further studies are required for the elucida-
tion of these mechanisms.
These results also corroborate with those obtained
with the ethanolic extract of S. biafrae,b u tw i t hd i f f e r -
ent dosages. Thus, AESb would be less active than the
ethanolic extract of the plant in inducing precocious
puberty in immature female rats, but more safer for
gestation. The therapeutic dose used by traditional med-
icine practitioners is able to stimulate folliculogenesis,
but have a little effect on the maturation of the repro-
ductive axis; for a better effect, this therapeutic dose
should be increased. Unfortunately, high doses after 30
Table 3 Effect of AESb on some fertility and gestational parameters
Studied parameters Dosage (mg/kg/Day)
083 2 6 4
N°Corpora Lutea 11.9 ± 0.31 11.57 ± 0.61 11.43 ± 0.90 10.33 ± 1.50
N°Implantation sites 10.80 ± 0.44 10.43 ± 0.57 10.43 ± 0.75 9.00 ± 1.48
N° Fetuses Alive 9.50 ± 0.50 9.29 ± 0.52 9.86 ± 0.77 7.83 ± 1.68
N°Resorption sites 1.30 ± 0.47 1.00 ± 0.44 0.57 ± 0.43 1.17 ± 0.48
Mean weight of fetuses (g) 4.87 ± 0.09 5.16 ± 0.17 5.24 ± 0.28 5.27 ± 0.13
Fixation rate (%) 90.93 ± 3.36 91.10 ± 5.15 91.77 ± 1.72 84.58 ± 5.06
Preimplantation Loss (%) 9.07 ± 3.36 8.90 ± 5.15 8.23 ± 1.72 15.42 ± 5.06
Postimplantation Loss (%) 0.12 ± 0.04 0.11 ± 0.04 0.05 ± 0.04 0.25 ± 0.16
Antiimplantation Activity (%) 0 0 0 14.29
Antifertility Activity (%) 0 0 0 28.57
Resorption Index (%) 12.037 9.589 5.480 12.963
Gestation Rate (%) 100 100 100 85.71
Each value represents the mean ± SEM for 7 animals.
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Page 7 of 9days of treatment exhibit adverse effects on gestational
parameters. So, the length of the treatment with these
doses should be shortened.
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